Translocation t(15;17) in acute myelogenous leukemia with atypical megakaryoblastic features: diagnostic, clinical, and therapeutic implications

Cancer Genetics and Cytogenetics
D L MorganV Tonk

Abstract

We describe the first reported case of acute myelogenous leukemia with characteristics of megakaryoblastic differentiation and the t(15;17) chromosomal translocation, which has been associated with promyelocytic leukemia. The diagnostic, clinical, and therapeutic implications are discussed.

References

Dec 1, 1992·British Journal of Haematology·G J Ruiz-ArgüellesG Ruiz-Reyes
May 26, 1991·The New England Journal of Medicine·R P WarrellA Jakubowski
Nov 1, 1989·Mayo Clinic Proceedings·A M Gewirtz
May 1, 1986·The American Journal of Medicine·H M KantarjianE J Freireich
Dec 1, 1985·Cancer Genetics and Cytogenetics·L ParreiraD Catovsky
Oct 30, 1971·Lancet·M Seabright

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.